A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 11344
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GVHD
Long Form : graft-versus-host disease
No. Year Title Co-occurring Abbreviation
2021 "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service. BMT, QoL
2021 A bi-centric experience of extracorporeal carbon dioxide removal (ECCO2 R) for acute hypercapnic respiratory failure following allogeneic hematopoietic stem cell transplantation. ARF, HSCT
2021 A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance. BM, HPC, HSPC, SOT, vBA-MSC, VCA
2021 A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy. ADCC, CRS, NK
2021 A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation. aGVHD, cGVHD, CI, haplo-HCT, HCT, MMF, NIH, PB, PTCy
2021 A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis. aGVHD, CI, HR, MSD, TCZ, VUD
2021 A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients. allo-SCT
2021 A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. allo-HCT
2021 A survey of accuracy of nurses' clinical judgement of cutaneous graft-versus-host disease in Japan. CTCAE
10  2021 Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality. CI, HCT, HR, NRM
11  2021 Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study. ERC
12  2021 Acute Pulmonary Graft-Versus-Host Disease in a Patient with Adult T-cell Leukemia-Lymphoma Diagnosed by a Cryobiopsy. ---
13  2021 Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies. allo-HCT, RIC
14  2021 Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria. AA, HSCT, PNH
15  2021 Advances in the treatment of graft-versus-host disease with immunomodulatory cells. allo-HSCT, CAR, MSCs
16  2021 Allogeneic Haematopoietic Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma. allo-HSCT, CR, ENKL, GVL
17  2021 Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis. allo-HCT, FBM
18  2021 Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia. allo-HCT, CBT, GRFS, HLA, LFS, MMUD, NRM, OS, PTCy
19  2021 Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. allo-SCT, ASCT, DLBCL, EFS, NRM, OS, R/R
20  2021 Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers. allo-SCT, DFS, ECOG, NK, OS
21  2021 Allogeneic stem cell transplantation with omidubicel in sickle cell disease. HSCT, SCD, UCB
22  2021 Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. allo-HCT, cHL, CIs, PFS, PTCy
23  2021 Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors. DFS, HCT, HR, MDS, OS
24  2021 An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. AA, aGVHD, ATG, CY, Flu, HSCT, MRD, OS
25  2021 An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation. CI, CMV, HI, HR, HSCT, IMD, OS, SES
26  2021 An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT. ALC, HBV, Hib, HSCT, IgG, VPDs
27  2021 Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation. CNI, ES, HSCT, PRES
28  2021 Antimicrobial photodynamic therapy for recurrent herpes labialis in chronic graft-versus-host disease: A case report. aPDT, BMT, HHV-1
29  2021 Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients. allo-HSCT, CsA, MMF, MPA, MTX, TDM
30  2021 Association Between Baseline Patient-Reported Outcomes and Complications of Hematopoietic Stem Cell Transplantation. HCT, OR, PROs, QoL
31  2021 Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis. allo-HSCT, CIs, CTLA-4, DFS, OS
32  2021 Association of obesity with mortality and clinical outcomes in children and adolescents with transplantation: A systematic review and meta-analysis. ---
33  2021 Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. allo-HSCT, GM
34  2021 Azacitidine maintenance therapy post-allogeneic stem cell transplantation in poor-risk acute myeloid leukemia. AML, HSCT
35  2021 Case Report: Calpainopathy Presenting After Bone Marrow Transplantation, With Studies of Donor Genetic Content in Various Tissue Types. ---
36  2021 Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD. allo-HSCT, AML, FCM, HMAs, irAEs, MDS, MRD, PD, ts, WT1
37  2021 Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma. allo-HCT, ARDS, auto-HCT, COVID-19, DLI, HL, PTLD
38  2021 CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases. BM, BW, HSCT, MUD, PBSCs, PIDs, PTLD
39  2021 CD52/GPI- T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation. ---
40  2021 Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. allo-HSCT, AML, CCI, MDS, OS
41  2021 Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy. CAR
42  2021 Clinical development of natural killer cells expressing chimeric antigen receptors. CAR, NK
43  2021 Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation. BKV, CI, CMV, haplo-HSCT, HR, PTCy, UD-HSCT
44  2021 Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide. DLIs, Haplo-HSCT
45  2021 Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease. AIH, CTLA-4, FOXP3, ICIs, irAEs, PD-1
46  2021 Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation. ALL, CAR, CR, EMD
47  2021 Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance. LT, Th1, Th17, Treg
48  2021 Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome. HLA, KIR, MDS, SAA, UCB
49  2021 Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplant Recipients with Acute Myelogenous Leukemia with MRD Negative Disease at the Time of Transplant: A Retrospective Cohort Study. AML, CR, ECOG, ELN, HSCT, MAC, MRD, NRM, OS, RFS, RIC
50  2021 Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. allo-HCT, CNI, RAPA, Treg
51  2021 Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment. SCID
52  2021 Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells. HSCT, RIC, SCD
53  2021 Cost comparison of extracorporeal photopheresis technologies at the European Institute of Oncology. ECP, IEO
54  2021 Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy. allo-SCT, ASCT, PI3Ki
55  2021 CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells. IDAA, TCR, TIDE
56  2021 Critical roles of TLRs on the polarization of mesenchymal stem cells for cell therapy of viral infections: a notice for COVID-19 treatment. COVID-19, MSCs, TLRs
57  2021 Current Concepts and Advances in Graft-Versus-Host Disease Immunology. ---
58  2021 Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers. allo-HSCT, PN
59  2021 Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies. HSCT
60  2021 Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. CAR
61  2021 Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation. HSCT, TBI
62  2021 Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy. CsA, HID-HSCT
63  2021 Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies. ABMT, HCT, MRD, MUD, UCB
64  2021 Dermatological signs in liver transplant recipients. ---
65  2021 Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation. allo-HSCT, EVs, miRNA
66  2021 Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease. CI, DPP-4
67  2021 Distribution of MICA alleles and haplotypes associated with HLA-B in Greek population. MICA
68  2021 Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome? FA, FC, HCT, MC, MDS, OS
69  2021 Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease. HSCT, L/L
70  2021 Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. CI, CRS
71  2021 Early-Phase Peripheral Blood Eosinophilia Predicts Lower Overall and Non-Relapse Mortality After Single-Unit Cord Blood Transplantation. CBT, HCT, HR
72  2021 Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States. allo-HCT, HC, HRU, ICU
73  2021 Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia. CNI, MMF, MTX, UCBT
74  2021 Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases. AIDs, BD, CD, HCT, MS, RA, SSc, T1DM, UC
75  2021 Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect. allo-HCT, GMP, GVL, HuMoSC
76  2021 Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide. aGVHD, haplo-HSCT, PTCy
77  2021 Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology. CAR, NK
78  2021 Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse. CH, CHIP, HCT, IST
79  2021 Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report. EF, MRI
80  2021 Epigenetic-based therapy in allogenic hematopoietic stem cell transplantation: Novel opportunities for personalized treatment. allo-HSCT, DNMTi, HDACi
81  2021 Estimating health state utilities in hemophagocytic lymphohistiocytosis. HLH, SCT, TTO
82  2021 Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation. PGF
83  2021 Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation. ATG, HaploHCT, HR, NRM, OS, PTCy, RFS
84  2021 Extracorporeal Photopheresis in Pediatric Graft-vs-Host Disease. ECP
85  2021 Eye amputation following lifitegrast treatment for ocular graft-versus-host disease: First case report. AML
86  2021 Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies. DLI
87  2021 Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AL, AML/ALL, CR, CRi, EBMT, PFS/OS
88  2021 Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients. CBT, sMTX
89  2021 Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA. aGVHD, cGVHD, EFS, haplo-HSCT, MSD-HSCT, OS, PBSCs, PTCy, SAA, UC-MSCs
90  2021 First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings. IL-2, iTregs, MMF, PBSCs, TGF-beta
91  2021 Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive Therapy. 18F-FDG, allo-SCT, CI, OS
92  2021 G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study. AL, G-PB, HID, HID-PBSCT, HSCT, LFS, OS
93  2021 Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation. aGVHD, DRP, mHAs, MRD, MUD
94  2021 Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review. allo-HSCT, ICI
95  2021 Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice. BM, HSCT, STAP, Tg
96  2021 Graft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging Study. ALL, AML, CI, CRS, GVL, HSCT, MMF, PTB
97  2021 Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions. CNI, GRFS
98  2021 Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. CAR, HCT
99  2021 Graft-Versus-Host-Disease of the Central Nervous System and Lung in a Patient With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. allo-HSCT, CNS
100  2021 GVHD Prophylaxis 2020. ---